The Anti-ACVR2A Antibody (Ab-14E1) is a recombinant human monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells. It specifically targets the ACVR2A receptor, which plays a crucial role in the TGF-beta signaling pathway, influencing cellular processes such as proliferation and differentiation. This antibody is comprised of an IgG1 heavy chain and a human kappa (huκ) light chain, and has a molecular weight of approximately 150 kDa. For experimental control purposes, the Human IgG1 kappa, Isotype Control is recommended as an appropriate isotype control for this antibody. This product is essential for research in cellular signaling and regulatory mechanisms, particularly in the context of developmental biology and cancer research.
The Anti-ACVR2A Antibody (Ab-14E1) is a recombinant human monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells. It specifically targets the ACVR2A receptor, which plays a crucial role in the TGF-beta signaling pathway, influencing cellular processes such as proliferation and differentiation. This antibody is comprised of an IgG1 heavy chain and a human kappa (huκ) light chain, and has a molecular weight of approximately 150 kDa. For experimental control purposes, the Human IgG1 kappa, Isotype Control is recommended as an appropriate isotype control for this antibody. This product is essential for research in cellular signaling and regulatory mechanisms, particularly in the context of developmental biology and cancer research.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
Please check COA/MSDS for correct molecular weight.
Calculate the dilution required to prepare a stock solution.This equation is commonly abbreviated as: C1V1 = C2V2
Frequently Asked Questions
What are Biosimilar Antibodies?
Biosimilar antibodies are research-grade recombinant antibodies designed to closely resemble approved therapeutic antibodies in terms of amino acid sequence, structural characteristics, and biological activity. These antibodies are generated using recombinant expression technologies and retain the same variable regions as their corresponding reference therapeutics, thereby preserving target specificity and binding affinity. Owing to these properties, biosimilar antibodies serve as reliable and cost-effective research reagents for applications in drug discovery, pharmacological studies, and basic biomedical research.
Research-grade biosimilar antibodies have been successfully expressed and functionally validated against a wide range of widely studied targets. These antibodies can be directly utilized as positive control reagents in drug discovery programs, as well as reference tools for rapid verification of the biological functions of target proteins in biochemical and cellular assays.
